Organization

  • Founded in 2021 in Prague, Czech Republic, by Martin Tolar, MD, PhD
  • INDRC brings together leading experts from the fields of neurodegeneration and artificial intelligence to achieve breakthroughs in the treatment & prevention of Alzheimer’s disease and other neurodegenerative disorders
  • INDRC is a private, non-profit research institute, with transparent governance model and novel organization of research within an ecosystem of committed partners including universities, research institutes, clinical centers, and companies
Transparent governance model and financial management designed & supervised by

Functional Structure

Supervisory level

  • INDRC Assembly
  • Assembly of Founders

Executive level

  • Executive board
  • Director

Advisory level

  • Scientific board

Scientific level

  • Research Programs & Groups
  • INDRC Innovation Hub

Operational level

  • Director’s Office (HR, Finance & Legal)
  • Tech-Transfer & Innovation Management
  • Public Relations

Scientific Structure

Research programs

  • Brain Systems & Integrative Biology (BSB)
  • Brain Homeostatic Regulation & Clearance (BRC)
  • Proteomics & Protein Dynamics (PPD)
  • Bioinformatics & Artificial Intelligence (BIF)
  • Genetics & Genomics (GEN)
  • Socio-Economic Impacts (SEI)

3 world experts, among TOP 10 in the field

Research groups

  • Tenure track programs

6 tenure trackers with a team of 5-7 FTE each

INDRC innovation hub

  • Think trust for neurodegeneration R&D, bridge between scientific community, public sector & general public
  • Environment to foster new ideas & innovations, to exchange knowledge and interact with INDRC, its stakeholders & partners

200+ institutions 1000+ users

Advisory level

  • Scientific Board appointed by Director upon nomination: 3 members nominated by Executive Board, 6 members nominated by Assembly.

9 members